Racial gap in colon cancer diagnosis, treatment

Key points
- Later diagnosis and differences in treatment may be among the reasons that African Americans are less likely than whites to survive colon cancer, a study published Monday suggests.
- It has long been recognized that black Americans have a poorer colon cancer survival rate than their white counterparts, and recent studies suggest that the racial gap is growing rather than shrinking.
- In the new study, published online by the journal Cancer, researchers found a number of factors that may help explain the difference.
- Using government data on nearly 9,100 Americans diagnosed with colon cancer between 1988 and 1992, the researchers found that African Americans were 13 percent more likely to die within five years than white patients were.
Later diagnosis and differences in treatment may be among the reasons that African Americans are less likely than whites to survive colon cancer, a study published Monday suggests.
It has long been recognized that black Americans have a poorer colon cancer survival rate than their white counterparts, and recent studies suggest that the racial gap is growing rather than shrinking.
In the new study, published online by the journal Cancer, researchers found a number of factors that may help explain the difference.
Using government data on nearly 9,100 Americans diagnosed with colon cancer between 1988 and 1992, the researchers found that African Americans were 13 percent more likely to die within five years than white patients were.
In general, African Americans were more likely to have advanced cancer at diagnosis; nearly 48 percent were diagnosed with stage III or IV cancer - where the tumor has spread beyond the colon - compared with 43 percent of white patients.
There were also racial differences in the likelihood of having surgery, a treatment that was directly related to survival. Almost 17 percent of African Americans did not receive surgery, versus roughly 11 percent of whites.
When several factors were weighed - including socioeconomics, the stage of the cancer at diagnosis and type of treatment - race itself was no longer a predictor of survival.
That meant that the reasons for the disparities in treatment and cancer stage at diagnosis are not clear, said senior researcher Dr. Michael S. Simon, of the Karmanos Cancer Institute at Wayne State University in Detroit.
It's possible that African Americans were not getting screened for colon cancer as often or as early as whites, Simon told Reuters Health, but the National Cancer Institute database used for the study does not contain information on screening.
"The debate about the disparity (in colon cancer survival) has basically been whether it's related to genetics or socioeconomics," Simon said, adding that he thinks it is the latter.
Differences in access to good healthcare, diet and lifestyle may all play a role in African Americans' poorer colon cancer, according to Simon. He stressed that this study had no data on factors like diet and healthcare, but they are typically closely related to socioeconomics - which the study did link to colon cancer survival.
Another recent study, however, that appeared in the Journal of the National Cancer Institute, found that African Americans who developed breast, ovary, and prostate cancer had worse outcomes even when they received the same care. That suggested that "there is something that 'tracks' with African ancestry" for these three diseases, a co-author of that study, Dr. Kathy S. Albain of Loyola University Medical Center in Maywood, Illinois, told Reuters Health earlier this month.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsAfrican-American Women Delayed in Breast Cancer Diagnosis, Treatment & Clinical Care
A new study has found that African-American women experience the longest diagnostic, treatment and clinical delay of breast cancer treatment. This helps explain why African-American women have higher death rates from…
15 November 2006
NewsStudy Sets Treatment Standard for Elderly with Colon Cancer
One of the newest and most potent chemotherapies for colon cancer is as safe and effective for the elderly as it is for younger patients, based on a University of North Carolina at Chapel Hill-led data review. The…
14 February 2006
NewsAnti-tumor immunity identified with new ovarian cancer treatment strategy
Few effective treatments have been approved to treat ovarian cancer , the deadliest of all cancers affecting the female reproductive system. Now, new research from The Wistar Institute demonstrates how a drug already in…





